Total planned funding: $583,915,009
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $583,915,009 |
Organizational Types
NGO | $160,859,780 |
Private Contractor | $112,530,266 |
Host Country Government Agency | $88,691,099 |
Own Agency | $78,533,002 |
Unknown | $64,925,208 |
University | $44,945,708 |
Parastatal | $11,007,778 |
Implementing Agency | $9,314,795 |
FBO | $5,342,367 |
Other USG Agency | $4,621,248 |
Multi-lateral Agency | $3,143,758 |
Program Areas
Treatment | $151,864,821 |
Care | $120,690,846 |
Prevention | $118,252,806 |
Governance and Systems | $91,498,394 |
Management and Operations | $61,472,152 |
Testing | $40,135,990 |
Budget Codes
HTXS: Treatment: Adult Treatment | $126,219,539 |
HVMS: Management and Operations | $61,472,152 |
HKID: Care: Orphans and Vulnerable Children | $50,481,067 |
OHSS: Health Systems Strengthening | $45,701,714 |
HVCT: Testing: HIV Testing and Counseling | $40,135,990 |
HVOP: Sexual Prevention: Other Sexual Prevention | $38,953,145 |
HVSI: Strategic Information | $34,875,136 |
HBHC: Care: Adult Care and Support | $34,486,138 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $30,976,443 |
HVTB: Care: TB/HIV | $22,831,318 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $21,447,869 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $20,904,246 |
PDTX: Treatment: Pediatric Treatment | $13,814,649 |
PDCS: Care: Pediatric Care and Support | $12,892,323 |
HTXD: Treatment: ARV Drugs | $11,830,633 |
HLAB: Laboratory Infrastructure | $10,921,544 |
HMBL: Biomedical Prevention: Blood Safety | $4,117,678 |
HMIN: Biomedical Prevention: Injection Safety | $1,853,425 |
Top Partner Programs
Potentia Namibia:
$66,747,172
Countries/Regions
Not Available:
$49,016,315
Countries/Regions
University of Washington:
$45,274,594
Countries/Regions
USG Aggregated Agencies:
$42,894,996
Countries/Regions